Stefan Störkel
About
In The Last Decade
Stefan Störkel
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Immunology 539
- Molecular Biology 429
- Oncology 379
- Pulmonary and Respiratory Medicine 255
- Cancer Research 192
Countries citing papers authored by Stefan Störkel
This map shows the geographic impact of Stefan Störkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Störkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Störkel more than expected).
Fields of papers citing papers by Stefan Störkel
This network shows the impact of papers produced by Stefan Störkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Störkel. The network helps show where Stefan Störkel may publish in the future.
Co-authorship network of co-authors of Stefan Störkel
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Störkel. A scholar is included among the top collaborators of Stefan Störkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Störkel. Stefan Störkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 105 | |
| 7 | 49 | |
| 8 | 81 | |
| 9 | Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies? | 133 |
| 10 | 92 | |
| 11 | Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. | 82 |
| 12 | 179 | |
| 13 | 7 | |
| 14 | 15 | |
| 15 | 53 | |
| 16 | 39 | |
| 17 | 10 | |
| 18 | 7 | |
| 19 | 27 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.